Jane Street Group, LLC Forma Therapeutics Holdings, Inc. Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$5.1 - $10.0 $93,177 - $182,700	-18,270 Reduced 54.09%	15,510 $107,000
Q1 2022 May 17, 2022	BUY	$8.34 - $14.69 $281,725 - $496,228	33,780 New	33,780 $314,000
Q2 2021 Aug 16, 2021	SELL	$22.86 - $30.95 $513,161 - $694,765	-22,448 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$24.58 - $42.82 $185,628 - $323,376	7,552 Added 50.7%	22,448 $629,000
Q4 2020 Feb 17, 2021	BUY	$34.9 - $51.08 $519,870 - $760,887	14,896 New	14,896 $520,000
Q3 2020 Nov 17, 2020	SELL	$32.95 - $50.25 $914,000 - $1.39 Million	-27,739 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$39.0 - $46.49 $1.08 Million - $1.29 Million	27,739 New	27,739 $1.29 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.